Andrew R. Rezvani, MD
Patient Care Philosophy:
Most decisions regarding hematopoietic cell transplantation are not black-and-white, but are based on the values and treatment preferences of individual patients. I see my role as helping to guide patients through the complex balance of risk and benefit so that they can make decisions about their treatment that are right for them.
- Research Associate, Clinical Research Division, Fred Hutchinson Cancer Research Center
Hematopoietic cell transplantation, hematologic malignancies, non-Hodgkin's lymphoma, graft-vs.-host disease
I have worked at Fred Hutchinson Cancer Research Center and the University of Washington since 2005, specializing in the treatment of blood cancers through hematopoietic cell transplantation. In addition to seeing patients, I conduct clinical research seeking to improve treatment options for people with non-Hodgkin lymphoma, and to predict and effectively treat complications of transplantation such as graft-vs.-host disease.
Education And Training
- BA: Slavic Languages and Literature, Stanford University, Stanford, CA, 1997
- MD: Temple University School of Medicine, Philadelphia, PA, 2001
- Residency: Internal Medicine, Duke University Medical Center, Durham, NC, 2001-2004
- Fellowship: Medical Oncology, University of Washington & Fred Hutchinson Cancer Research Center, 2005-2008